Prevention of Non Communicable diseases in Unani System of Medicine
- Conditions
- Metabolic Syndrome
- Registration Number
- CTRI/2018/06/014407
- Lead Sponsor
- National Institute of Unani medicine
- Brief Summary
**Objectives of the Study****:**
To assess the efficacy of Unani personalized programme in the prevention of non-communicable diseases specifically cardiovascular diseases and Diabetes Mellitus-type 2.Unani personalized programme was more effective in reducing body weight,waist circumference and blood pressure at 60th day as compared to standard control drugs.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 50
Patients with three or more of the following features-3 1 Central obesity waist circumference > 90 cm in Male, >80 cm in Female 2 Hypertriglyceridemia; triglycerides ≥ 150 mg/dl 3 Low HDL cholesterol<40 mg/dl in males and <50 mg/dl in females 4 BP ≥130/ 85 mmHg 5 Fasting plasma glucose ≥ 100mg/dl.
1 All types of heart, liver and kidney diseases 2 Pregnancy 3 Lactation 4 Type-1 Diabetes 5 Weight loss medication 6 Uncontrolled Diabetes type 2 and uncontrolled Hypertension.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 2 Lipid profile day zero and two months after starting trial 3 Hematocrit values day zero and two months after starting trial 1 Blood glucose fasting day zero and two months after starting trial
- Secondary Outcome Measures
Name Time Method 1 Blood pressure 2 Waist circumference
Trial Locations
- Locations (1)
National Institute of Unani Medicine
🇮🇳Bangalore, KARNATAKA, India
National Institute of Unani Medicine🇮🇳Bangalore, KARNATAKA, IndiaNida TalatPrincipal investigator7204985692nidatalat1987@gmail.com